Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

CodeSystem: Kenya SHA Oncology Interventions Code System

Official URL: https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs Version: 0.1.0
Active as of 2026-06-04 Computable Name: SHAInterventionsCS

Social Health Authority (SHA) benefit package codes for oncology interventions.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs defines the following codes:

CodeDisplayDefinition
SHA-CHEMO-FIRST-LINE SHA: Chemotherapy — First Line First-line chemotherapy regimen.
SHA-CHEMO-SECOND-LINE SHA: Chemotherapy — Second Line Second-line or salvage chemotherapy.
SHA-CHEMO-ADJUVANT SHA: Chemotherapy — Adjuvant Post-surgery adjuvant chemotherapy.
SHA-CHEMO-NEO-ADJUVANT SHA: Chemotherapy — Neo-adjuvant Pre-surgery neo-adjuvant chemotherapy.
SHA-CHEMO-PALLIATIVE SHA: Chemotherapy — Palliative Palliative intent chemotherapy.
SHA-RT-RADICAL SHA: Radiotherapy — Radical Curative radiotherapy course.
SHA-RT-PALLIATIVE SHA: Radiotherapy — Palliative Palliative radiotherapy course.
SHA-RT-ADJUVANT SHA: Radiotherapy — Adjuvant Post-surgery adjuvant radiotherapy.
SHA-RT-CONCURRENT-CRT SHA: Concurrent Chemo-Radiotherapy Chemotherapy and radiotherapy delivered concurrently.
SHA-SURGERY-CURATIVE SHA: Surgery — Curative Cancer surgery with curative intent.
SHA-SURGERY-PALLIATIVE SHA: Surgery — Palliative Palliative or debulking surgery.
SHA-BMT-AUTOLOGOUS SHA: BMT — Autologous Autologous bone marrow / stem cell transplant.
SHA-BMT-ALLOGENEIC SHA: BMT — Allogeneic Allogeneic bone marrow / stem cell transplant.
SHA-HORMONAL-THERAPY SHA: Hormonal Therapy Hormone therapy for hormone-responsive cancers.
SHA-TARGETED-THERAPY SHA: Targeted Therapy Targeted molecular therapy / immunotherapy.
SHA-SUPPORTIVE-CARE SHA: Supportive / Supportive Care Supportive medications and G-CSF.
SHA-PAIN-MANAGEMENT SHA: Palliative Pain Management Opioid and pain management for cancer.
SHA-CANCER-SCREENING SHA: Cancer Screening Covered cancer screening tests (cervical, breast).
SHA-BIOPSY SHA: Diagnostic Biopsy Tissue biopsy for cancer diagnosis.
SHA-IMAGING SHA: Oncology Diagnostic Imaging CT, MRI, PET-CT for staging or response.
SHA-ONCOLOGY-CONSULT SHA: Oncology Consultation Specialist oncology consultation.
SHA-MDT SHA: MDT Meeting Multidisciplinary tumour board review.
SHA-PATHOLOGY SHA: Pathology / Histopathology Histopathology, IHC, or molecular diagnostics.
SHA-RT-DOSE-PER-FRACTION SHA: RT Dose Per Fraction Radiation dose delivered per fraction (Gy).
SHA-RT-TOTAL-FRACTIONS SHA: RT Total Fractions Delivered Total number of radiation fractions delivered.
SHA-SUSPECTED-CANCER-TYPE SHA: Suspected Cancer Type Type of cancer suspected at screening/referral.
SHA-SUSPICION-LEVEL SHA: Cancer Suspicion Level Clinical level of suspicion for malignancy.
SHA-REASON-FOR-SUSPICION SHA: Reason for Suspicion Reason underpinning the cancer suspicion.
SHA-PRESENTING-SYMPTOMS SHA: Presenting Symptoms Symptoms presented by the patient.
SHA-DIAGNOSTIC-WORKUP SHA: Planned Diagnostic Workup Diagnostic investigations planned for confirmation.

Description of the above table(s).